These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8133428)

  • 1. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
    Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
    J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.
    Kislalioglu MS; Khan MA; Blount C; Goettsch RW; Bolton S
    J Pharm Sci; 1991 Aug; 80(8):799-804. PubMed ID: 1791544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated stability of sulphamethoxazole microcapsules coated with Eudragit RS 100 and Eudragit RL 100.
    Basnet S; Ganesan M; Pal TK
    Boll Chim Farm; 2002; 141(3):202-9. PubMed ID: 12197419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
    Wu C; McGinity JW
    AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations.
    Mora PC; Cirri M; Mura P
    J Pharm Biomed Anal; 2006 Sep; 42(1):3-10. PubMed ID: 16574368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal treating of acrylic matrices as a tool for controlling drug release.
    Hasanzadeh D; Ghaffari S; Monajjemzadeh F; Al-Hallak MH; Soltani G; Azarmi S
    Chem Pharm Bull (Tokyo); 2009 Dec; 57(12):1356-62. PubMed ID: 19952444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.
    Azarmi S; Ghaffari F; Löbenberg R; Nokhodchi A
    Farmaco; 2005; 60(11-12):925-30. PubMed ID: 16223498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.